Q3 Earnings Forecast for McKesson Issued By Leerink Partnrs

McKesson Co. (NYSE:MCK) – Equities researchers at Leerink Partnrs increased their Q3 2025 earnings estimates for McKesson in a research report issued to clients and investors on Thursday, November 7th. Leerink Partnrs analyst M. Cherny now expects that the company will post earnings per share of $8.87 for the quarter, up from their previous estimate of $8.54. The consensus estimate for McKesson’s current full-year earnings is $31.92 per share. Leerink Partnrs also issued estimates for McKesson’s Q4 2025 earnings at $9.11 EPS, FY2025 earnings at $32.90 EPS and FY2028 earnings at $47.45 EPS.

McKesson (NYSE:MCK) last posted its quarterly earnings results on Wednesday, November 6th. The company reported $7.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.89 by $0.18. The business had revenue of $93.65 billion for the quarter, compared to analyst estimates of $89.33 billion. McKesson had a negative return on equity of 242.57% and a net margin of 0.94%. The business’s revenue was up 21.3% compared to the same quarter last year. During the same period in the prior year, the company posted $6.23 EPS.

A number of other brokerages have also recently weighed in on MCK. Wells Fargo & Company cut their price target on McKesson from $576.00 to $535.00 and set an “equal weight” rating on the stock in a report on Friday, September 13th. StockNews.com raised McKesson from a “hold” rating to a “buy” rating in a research note on Wednesday. Deutsche Bank Aktiengesellschaft dropped their price target on shares of McKesson from $623.00 to $579.00 and set a “buy” rating on the stock in a research report on Wednesday, September 25th. Leerink Partners decreased their price target on shares of McKesson from $665.00 to $630.00 and set an “outperform” rating on the stock in a research report on Monday, October 7th. Finally, Mizuho lifted their target price on McKesson from $540.00 to $570.00 and gave the stock a “neutral” rating in a report on Thursday, August 8th. Two research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, McKesson presently has an average rating of “Moderate Buy” and an average target price of $625.64.

McKesson Stock Performance

McKesson stock opened at $607.51 on Friday. McKesson has a 1 year low of $431.35 and a 1 year high of $637.51. The firm’s 50-day moving average is $510.96 and its 200-day moving average is $550.61. The company has a market cap of $78.78 billion, a P/E ratio of 27.17, a PEG ratio of 1.23 and a beta of 0.44.

Institutional Investors Weigh In On McKesson

A number of hedge funds and other institutional investors have recently made changes to their positions in MCK. LRI Investments LLC acquired a new position in McKesson during the 1st quarter worth approximately $28,000. Wolff Wiese Magana LLC increased its stake in McKesson by 742.9% in the 3rd quarter. Wolff Wiese Magana LLC now owns 59 shares of the company’s stock valued at $29,000 after buying an additional 52 shares during the last quarter. MidAtlantic Capital Management Inc. bought a new stake in McKesson during the 3rd quarter worth about $29,000. ORG Wealth Partners LLC acquired a new position in shares of McKesson during the 3rd quarter worth about $40,000. Finally, Carmichael Hill & Associates Inc. bought a new position in shares of McKesson in the 2nd quarter valued at about $52,000. 85.07% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at McKesson

In other news, CEO Brian S. Tyler sold 3,753 shares of the company’s stock in a transaction dated Thursday, September 5th. The stock was sold at an average price of $561.10, for a total value of $2,105,808.30. Following the completion of the sale, the chief executive officer now directly owns 78,586 shares of the company’s stock, valued at $44,094,604.60. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Corporate insiders own 0.11% of the company’s stock.

McKesson Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, January 2nd. Stockholders of record on Monday, December 2nd will be issued a dividend of $0.71 per share. This represents a $2.84 annualized dividend and a dividend yield of 0.47%. The ex-dividend date of this dividend is Monday, December 2nd. McKesson’s payout ratio is 12.70%.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.